TheraDoc vs VigiLanz
The two incumbent clinical surveillance platforms in American hospitals, and a comparison most pharmacy directors have run at least once at renewal. Both watch live laboratory, microbiology, pharmacy and admission feeds and raise alerts for stewardship, infection prevention and pharmacy surveillance, and both route those alerts to a pharmacist rather than acting on an order. VigiLanz reaches wider by setting, covering acute, post acute and ambulatory care, and ingests from any record system. TheraDoc publishes more about its own security posture, names national health information technology certification and third party testing, and covers mandatory infection reporting alongside stewardship. The important thing for a buyer is what neither is: both engines evaluate rules the hospital's own staff wrote, so the right diligence question is how those rules are validated and retired, not what the model accuracy is.
- Coverage is broadest by setting, spanning acute, post acute and ambulatory care, which is wider than its principal competitor and matters for a system that has grown beyond the hospital.
- Interoperability is the core competence rather than an add on, ingesting near real time clinical data regardless of which record system produced it, so a mixed estate is not an obstacle.
- Rules are customer configurable, so the institution's own pharmacists own the alert logic and can read every criterion that fires.
- The security page names three specific things rather than gesturing at them, including national health information technology certification and third party vulnerability testing, where the competitor publishes no attestation at all.
- Functional breadth within acute care is genuine, spanning infection prevention with mandatory reporting to the national surveillance network, antimicrobial stewardship, pharmacy surveillance and anticoagulation management in one platform.
- The alert path is clearly bounded: a clinical pharmacist or infection preventionist investigates and acts, and the platform never touches an order.
Side by Side
| Axis | T TheraDoc |
V VigiLanz |
|---|---|---|
| AI Centrality | ||
| Autonomy and Oversight Model | ||
| Model and Technology Transparency | ||
| Clinical and Operational Evidence | ||
| AI Safety and PHI Stewardship | ||
| HIPAA and BAA Posture | ||
| Security Certifications and Trust Center | ||
| FDA and Regulatory Status | ||
| AI Governance and Bias Disclosure | ||
| EHR and Interoperability Depth | ||
| Deployment Model and Data Residency | ||
| Commercial Transparency | ||
| Setting and Specialty Coverage |
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Clinical Decision Support page.
Both vendors describe their engines in AI terms and both are rules engines. One product page uses the phrase flexible rule based AI, which is the clearest instance in this index of the label being applied to logic a hospital's own staff wrote. That is not a criticism of the products, since a rules engine is transparent by construction and a learned model is not, but it should change what a buyer asks for: rule validation methodology rather than model accuracy.
Neither publishes performance by patient characteristic, a rule validation method or a post deployment monitoring statement. VigiLanz publishes no located security attestation, trust centre or business associate terms. Neither publishes pricing.